{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:01:35Z","timestamp":1793394095879,"version":"4.5.0"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.2169\/internalmedicine.4449-24","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T22:11:54Z","timestamp":1729203114000},"page":"1733-1736","source":"Crossref","is-referenced-by-count":1,"title":["Bortezomib Led to Remission of Immune Thrombocytopenic Purpura in a Patient with Smoldering Multiple Myeloma"],"prefix":"10.2169","volume":"64","author":[{"given":"Akane","family":"Yamano","sequence":"first","affiliation":[{"name":"Department of hematology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Department of hematology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of hematology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Esaki","sequence":"additional","affiliation":[{"name":"Department of hematology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Masaie","sequence":"additional","affiliation":[{"name":"Department of hematology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Tadokoro","sequence":"additional","affiliation":[{"name":"Department of hematology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kosugi","sequence":"additional","affiliation":[{"name":"Department of hematology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kida","sequence":"additional","affiliation":[{"name":"Department of hematology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78: 21-33, 2003.","DOI":"10.4065\/78.1.21"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Barcellini W, Giannotta JA, Fattizzo B. Autoimmune Complications in Hematologic Neoplasms. Cancers (Basel) 13: 1532, 2021.","DOI":"10.3390\/cancers13071532"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shimanovsky A, Alvarez Argote J, Murali S, Dasanu CA. Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. BBA Clin 6: 12-18, 2016.","DOI":"10.1016\/j.bbacli.2016.05.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gupta V, Hegde UM, Parameswaran R, Newland AC. Multiple myeloma and immune thrombocytopenia. Clin Lab Haematol 22: 239-242, 2000.","DOI":"10.1046\/j.1365-2257.2000.00125.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Faller E, Chapman L, Enright H, Browne P, McHugh J, Desmond R. Immune thrombocytopenia purpura associated with multiple myeloma. Ann Hematol 95: 1371-1372, 2016.","DOI":"10.1007\/s00277-016-2694-y"},{"key":"6","unstructured":"6. Itoh T. Multiple myeloma developing in a patient with immune thrombocytopenia. Rinsho Ketsueki (J Jpn Soc Hematol) 57: 630-633, 2016 (in Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sarfraz H, Anand K, Liu S, Shah S. Multiple myeloma with concurrent immune thrombocytopenic purpura. ecancer 14: 1012, 2020.","DOI":"10.3332\/ecancer.2020.1012"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Kiyomizu K, Kashiwagi H, Nakazawa T, et al. Recognition of highly restricted regions in the \u03b2-propeller domain of \u03b1IIb by platelet-associated anti-\u03b1IIb\u03b23 autoantibodies in primary immune thrombocytopenia. Blood 120: 1499-1509, 2012.","DOI":"10.1182\/blood-2012-02-409995"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. McGrath KM, Stuart JJ, Richards F, et al. Correlation between serum IgG, platelet membrane IgG, and platelet function in hypergammaglobulinaemic states. Br J Haematol 42: 585-591, 1979.","DOI":"10.1111\/j.1365-2141.1979.tb01171.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hegde UM, Ball S, Zuiable A, Roter BL. Platelet associated immunoglobulins (PAIgG and PAIgM) in autoimmune thrombocytopenia. Br J Haematol 59: 221-226, 1985.","DOI":"10.1111\/j.1365-2141.1985.tb02987.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol 14: 511-514, 2007.","DOI":"10.1097\/MOH.0b013e3282ba5552"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lee NCJ, Yates S, Rambally S, et al. Bortezomib in relapsed\/refractory immune thrombotic thrombocytopenic purpura: a single-centre retrospective cohort and systematic literature review. Br J Haematol 204: 638-643, 2024.","DOI":"10.1111\/bjh.19035"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Holzer MT, Ruffer N, Huber TB, K\u00f6tter I, Ostendorf L, Krusche M. Daratumumab for autoimmune diseases: a systematic review. RMD Open 9: e003604, 2023.","DOI":"10.1136\/rmdopen-2023-003604"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/11\/64_4449-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:39:07Z","timestamp":1749271147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/11\/64_4449-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4449-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"article-number":"4449-24"}}